azides has been researched along with B-Cell Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Du, J; Hampton, EN; Hardy, IR; Kim, CH; Ma, J; Mazagova, M; Nunez, V; Ramadoss, NS; Rodgers, DT; Schulman, A; Schultz, PG; Shen, J; Singer, O; Wang, F; Woods, AK; Wright, TM; Young, TS | 1 |
Cao, Y; Choi, SH; Fonslow, BR; Kazane, SA; Kim, CH; Kim, JY; Kim, MS; Kochenderfer, JN; Ma, JS; Pugh, HM; Rodgers, DT; Schultz, PG; Singer, O; Sun, SB; Wright, TM; Young, TS; Yun, HY | 1 |
2 other study(ies) available for azides and B-Cell Leukemia
Article | Year |
---|---|
Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies.
Topics: Animals; Antigens, CD19; Antigens, Neoplasm; Azides; B-Lymphocytes; Basic-Leucine Zipper Transcription Factors; Cell Line, Tumor; Cytokines; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Female; Genes, Reporter; Genetic Vectors; Humans; Immunotherapy, Adoptive; Leukemia, B-Cell; Lymphocyte Activation; Lymphopenia; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Phenylalanine; Protein Engineering; Receptors, Antigen, T-Cell; Recombinant Fusion Proteins; Saccharomyces cerevisiae Proteins; Sialic Acid Binding Ig-like Lectin 2; Single-Chain Antibodies; Structure-Activity Relationship; T-Cell Antigen Receptor Specificity; T-Lymphocyte Subsets; Xenograft Model Antitumor Assays | 2016 |
Versatile strategy for controlling the specificity and activity of engineered T cells.
Topics: Animals; Antigens, CD19; Antigens, Neoplasm; Azides; B-Lymphocytes; Cell Line, Tumor; Cytotoxicity, Immunologic; Female; Fluorescein-5-isothiocyanate; Genetic Vectors; Humans; Immunotherapy, Adoptive; Lentivirus; Leukemia, B-Cell; Lymphocyte Activation; Lymphopenia; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Models, Molecular; Phenylalanine; Protein Conformation; Protein Engineering; Receptors, Antigen, T-Cell; Recombinant Fusion Proteins; Sialic Acid Binding Ig-like Lectin 2; Single-Chain Antibodies; T-Cell Antigen Receptor Specificity; T-Lymphocytes; Transduction, Genetic; Xenograft Model Antitumor Assays | 2016 |